Inactive Instrument

Nimutan AB (publ)

NIMU

SE0001789793

Medicanatumin AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021

August 24, 2021 at 02:30 am EDT

MedicaNatumin AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was SEK 49,005 compared to SEK 54,244 a year ago. Operating loss was SEK 13,373 compared to SEK 2,423 a year ago. Net loss was SEK 14,275 compared to SEK 2,556 a year ago. Basic loss per share from continuing operations was SEK 0.038 compared to SEK 0.0068 a year ago. For the half year, sales was SEK 108,286 compared to SEK 116,297 a year ago. Operating loss was SEK 15,310 compared to SEK 3,141 a year ago. Net loss was SEK 16,625 compared to SEK 3,759 a year ago. Basic loss per share from continuing operations was SEK 0.0442 compared to SEK 0.01 a year ago.

Latest news about Nimutan AB (publ)

Nimutan AB agreed to Spin-Off 1.6% stake in Humble Group AB (OM:HUMBLE).	22-11-02	CI
Nimutan AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-29	CI
Nimutan AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
MedicaNatumin AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-03	CI
Medicanatumin AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-24	CI
MedicaNatumin AB Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-13	CI
MedicaNatumin AB acquired Vitalkost AS for NOK 26 million.	19-12-15	CI
Medica Clinical Nord Holding AB Reports Consolidated Earnings Results for the Six Months Ended June 30, 2017	17-08-24	CI
TJ Gruppen AB and JOOL Invest AB cancelled the acquisition of 11.77% stake in Medica Clinical Nord Holding AB from QV Private Equity AB.	16-05-25	CI
Medica Clinical Nord Holding AB (NGM:MCNH MTF) acquired Natumin Pharma AB for SEK 31.5 million.	16-03-16	CI
TJ Gruppen AB and JOOL Invest AB agreed to acquire 11.77% stake in Medica Clinical Nord Holding AB from QV Private Equity AB.	15-05-25	CI
The founders acquired an additional 3.36% stake in Medica Clinical Nord Holding AB from QV Private Equity AB.	15-05-12	CI
Scandinavian Clinical Nutrition i Sverige AB completed the acquisition of Medica Clinical Nord AB from QV Private Equity AB, Bengt Johansson, Karl-Olov Eriksson and others.	14-04-25	CI
Scandinavian Clinical Nutrition i Sverige AB signed an agreement to acquire Medica Clinical Nord AB from QV Private Equity AB, Bengt Johansson, Karl-Olov Eriksson and others.	13-04-25	CI

Chart Nimutan AB (publ)

Duration

Period

More charts

Company Profile

Nimutan AB (publ), formerly MedicaNatumin AB is a Sweden-based healthcare products company that develops and manufactures dietary supplements, medical devices and dermatological and cosmetic products. The Company's series consist of documented products in men's and women's health, general health and skin care. The products fall into the categories of dietary supplements, medical technology and dermatological and cosmetic products. The brands include dietary supplements such as L-Argiplex and Nypozin and the scientifically documented skin care series Jabushe. The Company also has the distribution rights for dietary supplements such as Astaxin, Ester-C and Kyolic. Nimutan AB is certified according to Svensk Egenvard's system for safe dietary supplements for consumers.

Sector

Food Processing

More about the company

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG NHU COMPANY LTD.	+11.32%	8.01B
BELLRING BRANDS, INC.	+1.64%	7.36B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.50%	6.54B
BYHEALTH CO., LTD	-6.69%	3.73B
THE SIMPLY GOOD FOODS COMPANY	-12.50%	3.42B
XIAMEN KINGDOMWAY GROUP COMPANY	-10.10%	1.24B
SIRIO PHARMA CO., LTD.	+8.34%	935M
HERBALIFE LTD.	-43.38%	886M
USANA HEALTH SCIENCES, INC.	-20.69%	827M

Special Foods & Wellbeing Products